Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,293 total articles
Immunome Inc. director Isaac Barchas has completed a series of indirect stock sales totaling $4,393,024 across June and July 2026. The transactions, executed through entities ABHMC II LLC and Arsenal Bridge Venture II-B LLC, were structured under pre-established Rule 10b5-1 trading plans adopted in March 2026. While the sales occurred after a signi…
Several major stakeholders in Jewett-Cameron Trading Co Ltd (NASDAQ:JCTC), including AJB Investment Fund II, LP, AJB Capital, LLC, Adam James Bradley, and Melinda Hodges Bradley, have collectively purchased $25,871 worth of company stock. The acquisition of 11,009 shares occurred on July 1, 2026, at a price of $2.35 per share. This strategic buying…
Matthew David Feierstein, president of EverCommerce Inc. (NASDAQ: EVCM), completed three separate sales of company stock between June 30 and July 2, 2026, totaling approximately $259,556. The transactions, executed under a Rule 10b5-1 plan established in August 2025, reduced his direct shareholding to 2,055,448 shares. The sales occur as EverCommer…
Edward Smolyansky, a significant 10% shareholder in Lifeway Foods, Inc. (NASDAQ:LWAY), executed a series of stock sales totaling approximately $5.18 million during the final days of June. The transactions occurred while the company's shares were trading near their 52-week highs, reflecting a period of substantial price appreciation. Despite the ins…
EverCommerce Inc. (NASDAQ: EVCM) Chief Executive Officer Eric Richard Remer recently divested a portion of his equity holdings through two separate transactions executed under a Rule 10b5-1 trading plan. The sales, totaling approximately $331,150, occurred over June 30 and July 1, 2026, at varying price points. Following these dispositions, Mr. Rem…
Scott Daniel Forney, General Counsel of MarketWise, Inc. (NASDAQ: MKTW), executed a share withholding transaction on July 1, 2026, to cover tax liabilities associated with the vesting of restricted stock units. The issuer withheld 711 shares at a price of $19.14 each, totaling $13,608. This administrative action does not constitute a sale by Forney…
Marco Galsim, Chief Information Officer at MarketWise, Inc. (NASDAQ: MKTW), executed a disposition of 3,294 shares of the company's Class A Common Stock on July 1, 2026. The transaction, valued at $19.14 per share for a total of $63,047, was facilitated through shares withheld to meet tax withholding and remittance obligations linked to the vesting…
Erik Mickels, Chief Financial Officer of MarketWise, Inc. (NASDAQ:MKTW), experienced a mandatory stock withholding event to satisfy tax obligations arising from the vesting of restricted stock units. The transaction involved 3,973 shares withheld at $19.14 per share, totaling $76,043. Following the withholding, Mr. Mickels retains direct ownership …
Abhinav Shukla, Chief Technical Officer at Shattuck Labs, Inc. (NASDAQ:STTK), executed two stock transactions totaling approximately $166,131 on June 30 and July 1, 2026. The sales, facilitated through a Rule 10b5-1 trading plan established in February 2026, were structured to cover the exercise price and estimated tax withholding for stock options…
Neil Blumenthal, co-CEO of Warby Parker Inc. (NYSE: WRBY), executed a significant divestiture of Class A Common Stock valued at approximately $6.4 million on July 1, 2026. The transaction involved the sale of 217,667 shares at an average price of $29.61, conducted under a pre-arranged Rule 10b5-1 trading plan established in March 2026. This sale co…
Warby Parker Inc. (NYSE:WRBY) co-CEO David Abraham Gilboa executed a significant stock sale on July 1, 2026, disposing of Class A Common Stock worth $7,191,541 under a Rule 10b5-1 trading plan adopted in March of that year. The transaction occurred as WRBY shares approached a 52-week high of $31, reflecting a 34% year-to-date gain. Concurrently, Gi…
CrowdStrike Holdings Inc. Chief Executive Officer George Kurtz executed a series of stock sales totaling approximately $1.94 million on July 1, 2026. The dispositions were carried out under the guidelines of a pre-arranged Rule 10b5-1 trading plan established in January 2026. These transactions occurred as CrowdStrike's equity experienced significa…
Shattuck Labs, Inc. (NASDAQ: STTK) has reported a significant insider transaction involving its Chief Medical Officer, Arundathy Pandite. On June 30, 2026, Pandite sold 30,000 shares of the company's common stock, generating a total transaction value of $210,300. The sale, executed under a Rule 10b5-1 trading plan established earlier in the year, o…
Jennifer F. Scanlon, President and CEO of UL Solutions Inc. (NASDAQ:ULS), sold a total of 12,500 shares of the company’s Class A Common Stock on July 1, 2026. The transactions amounted to a total value of $1,240,276. These sales were executed pursuant to a Rule 10b5-1 trading plan, which Ms. Scanlon adopted on December 9, 2025. The shares were sold…
Omada Health, Inc. (NASDAQ:OMDA) Chief Financial Officer Steven L. Cook executed a transaction involving the sale of company stock, according to a Form 4 filing. The sale occurred on June 30, 2026, and was part of a pre-arranged 10b5-1 trading plan adopted in March 2026. This activity comes as the company reports strong first-quarter financial resu…
Jeffrey Jacob Raider, a director at Warby Parker Inc. (NASDAQ:WRBY), executed a sale of 22,500 shares of Class A Common Stock on July 1, 2026, totaling $668,700. The transactions were conducted under a Rule 10b5-1 trading plan adopted earlier in the year. This sale occurs as the stock trades near its 52-week high, with analysts highlighting both va…
Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc. (NASDAQ: APGE), executed a series of stock transactions on July 1, 2026, involving both the acquisition and sale of company shares. The sales were conducted under a pre-arranged trading plan, while the purchases stemmed from exercised stock options. This activity occurs against the…
Omada Health, Inc. (NASDAQ:OMDA) Chief Accounting Officer Craig Gracey executed a series of share transactions in late June and early July 2026, selling stock valued at $23,561 while simultaneously exercising options for shares worth $6,845. These moves occurred as the company’s stock surged 50% over the prior six months, currently trading at $22.3…
Atlanticus Holdings Corp (NASDAQ:ATLC) President and CEO Jeffrey A. Howard executed a structured sale of 10,000 shares on June 30, 2026, netting $1,030,100 at a weighted average price of $103.01. The transaction reduces his direct holdings to 663,265 shares. This insider activity unfolds against a backdrop of mixed Q1 2026 financial results, where …
Atlanticus Holdings Corp (NASDAQ: ATLC) Chief Financial Officer William McCamey executed a direct sale of 10,000 shares on June 30, 2026, totaling $1,030,100. The transaction occurred at prices between $103.00 and $103.50 per share. This sale reduces McCamey's direct holdings to 127,410 shares, though he maintains indirect ownership through an LLC …
Pinterest, Inc. (NASDAQ: PINS) Director Benjamin Silbermann, who holds a 10% ownership stake in the company, has executed a series of Class A Common Stock sales totaling approximately $2.02 million. The transactions, conducted through the Benjamin and Divya Silbermann Family Trust, took place in late June and early July 2026 under a Rule 10b5-1 tra…
McGrath RentCorp (NASDAQ:MGRC) director Joseph F. Hanna executed a significant sale of common stock on July 1, 2026, disposing of 7,500 shares for a total value of $904,817. The transactions occurred at weighted average prices between $119.208 and $121.2318 per share. Following the sale, Hanna retains direct ownership of 151,549 shares. The sale co…
Kevin Tang and Tang Capital Management LLC have executed a series of share purchases in Boundless Bio, Inc. (NASDAQ:BOLD), bringing their indirect ownership to 2,641,308 shares. The buying activity occurs as the biotechnology company navigates a definitive merger with Serapha Bio, a cash dividend declaration, and significant leadership appointments…
Saurabh Sinha, Chief Financial Officer of Aeva Technologies, Inc. (NASDAQ: AEVA), executed a non-discretionary sale of 11,212 shares of the company's common stock on July 2, 2026. The transaction, totaling $299,973, was structured to cover tax withholding obligations arising from the vesting of time-based restricted stock unit awards. Following thi…
Edward Smolyansky, a significant 10% shareholder in Lifeway Foods, Inc. (NASDAQ: LWAY), executed a series of sales totaling approximately $5.17 million in the company's common stock between June 26 and June 30, 2026. The transactions, reported via Form 4 filings with the Securities and Exchange Commission on July 2, 2026, occurred as the stock trad…
